Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 841 to 843 of 843 entries
Sorted by: Best Match Show Resources per page
DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.

Pharmacological research

Villa A, Brunialti E, Dellavedova J, Meda C, Rebecchi M, Conti M, Donnici L, De Francesco R, Reggiani A, Lionetti V, Ciana P.
PMID: 34798263
Pharmacol Res. 2021 Nov 16;175:105982. doi: 10.1016/j.phrs.2021.105982. Epub 2021 Nov 16.

All the different coronavirus SARS-CoV-2 variants isolated so far share the same mechanism of infection mediated by the interaction of their spike (S) glycoprotein with specific residues on their cellular receptor: the angiotensin converting enzyme 2 (ACE2). Therefore, the...

Cite
Villa A, Brunialti E, Dellavedova J, et al. DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic. Pharmacol Res. 2021;175:105982doi: 10.1016/j.phrs.2021.105982.
Villa, A., Brunialti, E., Dellavedova, J., Meda, C., Rebecchi, M., Conti, M., Donnici, L., De Francesco, R., Reggiani, A., Lionetti, V., & Ciana, P. (2021). DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic. Pharmacological research, 175105982. https://doi.org/10.1016/j.phrs.2021.105982
Villa, Alessandro, et al. "DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic." Pharmacological research vol. 175 (2021): 105982. doi: https://doi.org/10.1016/j.phrs.2021.105982
Villa A, Brunialti E, Dellavedova J, Meda C, Rebecchi M, Conti M, Donnici L, De Francesco R, Reggiani A, Lionetti V, Ciana P. DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic. Pharmacol Res. 2021 Nov 16;175:105982. doi: 10.1016/j.phrs.2021.105982. Epub 2021 Nov 16. PMID: 34798263; PMCID: PMC8594078.
Copy Download .nbib Format: NLM
The Medical Home Initiative in Italy: an Analysis of Changes in Healthcare Utilization.

Journal of general internal medicine

Keith SW, Waters D, Alcusky M, Hegarty S, Jafari N, Lombardi M, Pini M, Maio V.
PMID: 34357575
J Gen Intern Med. 2021 Aug 06; doi: 10.1007/s11606-021-07040-9. Epub 2021 Aug 06.

BACKGROUND: Seventeen medical homes (MHs) were established in the Local Health Authority (LHA) of Parma (about 450,000 residents), Emilia Romagna, Italy, between 2011 and 2016.OBJECTIVE: To estimate the effects of MH implementation on healthcare utilization.DESIGN: We conducted a longitudinal...

Cite
Keith SW, Waters D, Alcusky M, et al. The Medical Home Initiative in Italy: an Analysis of Changes in Healthcare Utilization. J Gen Intern Med. 2021;doi: 10.1007/s11606-021-07040-9.
Keith, S. W., Waters, D., Alcusky, M., Hegarty, S., Jafari, N., Lombardi, M., Pini, M., & Maio, V. (2021). The Medical Home Initiative in Italy: an Analysis of Changes in Healthcare Utilization. Journal of general internal medicine, . https://doi.org/10.1007/s11606-021-07040-9
Keith, Scott W, et al. "The Medical Home Initiative in Italy: an Analysis of Changes in Healthcare Utilization." Journal of general internal medicine vol. (2021). doi: https://doi.org/10.1007/s11606-021-07040-9
Keith SW, Waters D, Alcusky M, Hegarty S, Jafari N, Lombardi M, Pini M, Maio V. The Medical Home Initiative in Italy: an Analysis of Changes in Healthcare Utilization. J Gen Intern Med. 2021 Aug 06; doi: 10.1007/s11606-021-07040-9. Epub 2021 Aug 06. PMID: 34357575.
Copy Download .nbib Format: NLM
BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity.

Molecules (Basel, Switzerland)

Novais P, Silva PMA, Moreira J, Palmeira A, Amorim I, Pinto M, Cidade H, Bousbaa H.
PMID: 34885726
Molecules. 2021 Nov 25;26(23). doi: 10.3390/molecules26237139.

Previously, we reported the in vitro growth inhibitory effect of diarylpentanoid BP-M345 on human cancer cells. Nevertheless, at that time, the cellular mechanism through which BP-M345 exerts its growth inhibitory effect remained to be explored. In the present work,...

Cite
Novais P, Silva PMA, Moreira J, et al. BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity. Molecules. 2021;26(23)doi: 10.3390/molecules26237139.
Novais, P., Silva, P. M. A., Moreira, J., Palmeira, A., Amorim, I., Pinto, M., Cidade, H., & Bousbaa, H. (2021). BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity. Molecules (Basel, Switzerland), 26(23), . https://doi.org/10.3390/molecules26237139
Novais, Pedro, et al. "BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity." Molecules (Basel, Switzerland) vol. 26,23 (2021). doi: https://doi.org/10.3390/molecules26237139
Novais P, Silva PMA, Moreira J, Palmeira A, Amorim I, Pinto M, Cidade H, Bousbaa H. BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity. Molecules. 2021 Nov 25;26(23). doi: 10.3390/molecules26237139. PMID: 34885726; PMCID: PMC8659070.
Copy Download .nbib Format: NLM
Showing 841 to 843 of 843 entries